Anne M Wallace MD
Breast, Melanoma, Surgical Oncology (Other than Breast)
Professor of Clinical Surgery, UC San Diego // Director, Comprehensive Breast Health Center at Moores Cancer Center
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 858-822-6193
Fax+1 858-822-6194
Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am board certified in general surgery and plastic surgery and specialize in breast health, focusing on breast cancer and breast reconstruction. I also have experience in all forms of cosmetic breast and body-contouring surgery. My research focuses on developing better imaging technology to detect breast cancer and melanoma.
Education & Training
University of California (San Diego) Medical CenterResidency, Plastic Surgery - Integrated, 1992 - 1994
MedStar Health Georgetown University (D.C.)Residency, Surgery, 1987 - 1992
Creighton University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1991 - 2025
MA State Medical License 2014 - 2025
TX State Medical License 1994 - 1996
American Board of Plastic Surgery Plastic Surgery
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- Adhesion strength of tumor cells predicts metastatic disease in vivo.Madison A Kane, Katherine G Birmingham, Benjamin Yeoman, Neal Patel, Hayley Sperinde
Cell Reports. 2025-03-25 - Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.Judy C Boughey, Hongmei Yu, Kayla Switalla, Ladores Velle, Alex Lopes
Annals of Surgical Oncology. 2025-02-13 - Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.Hope S Rugo, Mike Campbell, Christina Yau, A Jo Chien, Anne M Wallace
Breast Cancer Research and Treatment. 2025-02-01
Press Mentions
Could an EHR Nudge Reduce Unnecessary Biopsies?July 18th, 2024- Breast Cancer Rate Rises in Women Under 40: What We Can DoFebruary 22nd, 2021
- San Diego’s Top Doctors 2020: The ListOctober 28th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
